Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
APAC to see a reduction in imported surgical robotics
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
The company has played an important role in the procurement and distribution of emergency medical supplies supporting the Union Health Ministry for Covid–19 pandemic management
Swiftmelt 1515-I meets performance requirements and secures skin attachment
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Subscribe To Our Newsletter & Stay Updated
